Economic Evaluation is Essential in Healthcare for the Elderly
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 13 (4) , 255-262
- https://doi.org/10.2165/00002512-199813040-00001
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Japanʼs Aging PopulationPharmacoEconomics, 1997
- Cost-effectiveness of carotid endarterectomy in asymptomatic patientsJournal of Vascular Surgery, 1997
- The Cost Effectiveness of Diclofenac Plus Misoprostol Compared with Diclofenac Monotherapy in Patients with Rheumatoid ArthritisPharmacoEconomics, 1996
- The impact of age on cost-effectiveness ratios and its control in decision makingHealth Economics, 1996
- An Economic Evaluation of Finasteride for Treatment of Benign Prostatic HyperplasiaPharmacoEconomics, 1996
- Heart FailurePharmacoEconomics, 1996
- Setting Limits: A ResponseThe Gerontologist, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient GroupsMedical Care, 1994
- The impact of aging on health care expenditure in SwedenHealth Policy, 1993
- Forecasting the impact of demographic change: the case of the British National Health ServiceHealth Policy, 1992